<DOC>
	<DOCNO>NCT02061813</DOCNO>
	<brief_summary>The purpose study determine irritation potential repeat application abametapir lotion normal skin .</brief_summary>
	<brief_title>Dermal Safety Study Evaluate Potential Irritation Abametapir Lotion</brief_title>
	<detailed_description>This randomize , evaluator-blind , single-center , control , within-subject comparison study investigational product ( abametapir lotion ) vehicle lotion positive negative control occlusive condition healthy volunteer . All subject investigational product ( abametapir lotion ) , vehicle product , positive control patch , negative control patch apply 4 randomly assign , adjacent skin site infrascapular area back , purpose determine irritation potential . The investigational product , vehicle , control apply one side infrascapular area back . Evaluation dermal reaction application site assess clinically use visual scale rate degree erythema , edema , sign cutaneous irritation ( see Section 3.5.5 ) . A total 21 application product make .</detailed_description>
	<criteria>1 . Are healthy ( confirmed medical history ) males female , 18 year age old ; 2 . In case female childbearing potential , use acceptable form birth control ( oral/implant/injectable/transdermal contraceptive , intrauterine device , condom spermicide , diaphragm spermicide , abstinence , partner 's vasectomy ) . Abstinence vasectomize partner acceptable female subject agree implement one acceptable method birth control lifestyle/partner change ; 3 . If female childbearing potential , negative urine pregnancy test ( UPT ) Day 1 , willing submit pregnancy test end study ( EOS ) ; 4 . Are free systemic dermatologic disorder , , opinion investigator , interfere study result increase risk adverse event ; 5 . Are skin type race , provide skin pigmentation allow discernment erythema ; 6 . Complete patch study Medical Screening form well Medical Personal History form ; 7 . Read , understand , provide sign informed consent . 1 . Have visible skin disease application site , opinion investigative personnel , interfere evaluation test site reaction ; 2 . Are willing refrain use topical/systemic analgesic aspirin ( daily use 81 mg aspirin acceptable ) , Aleve , Motrin , Advil , Nuprin 72 hour prior study ( occasional use acetaminophen permit ) ; 3 . Are use inhaled/systemic/topical corticosteroid 3 week prior study , systemic/topical antihistamine 72 hour prior study ; 4 . Are use medication , opinion investigative personnel , interfere study result , include antiinflammatory medication ; 5 . Are unwilling unable refrain use sunscreen , cosmetic , cream , ointment , lotion , similar product back study ; 6 . Have psoriasis and/or active atopic dermatitis/eczema ; 7 . Are females pregnant , plan become pregnant study , breastfeed child ; 8 . Have know sensitivity constituent present material evaluate ; 9 . Have damage skin around test site , include sunburn , excessively deep tan , uneven skin tone , tattoo , scar , excessive hair , numerous freckle , disfiguration test site 10 . Have receive treatment type internal cancer within 5 year prior study entry ; 11 . Have history , currently treat skin cancer ; 12 . Are currently participate clinical trial , 13 . Have know sensitivity adhesive ; and/or 14 . Have receive investigational treatment ( ) within 4 week prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Hatchtech</keyword>
</DOC>